Thomas L Popper

Title: The Innovations of Thomas L. Popper

Introduction

Thomas L. Popper is a notable inventor based in West Caldwell, NJ (US). He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroidal compounds with glucocorticoid activity. His work has implications for anti-inflammatory treatments, showcasing the importance of innovation in medical science.

Latest Patents

Thomas L. Popper holds a patent for "Azido-4,6-pregnadieno(3,2-c)pyrazoles." This patent describes processes for preparing steroidal 6-azido-4,6-pregnadieno[3,2-c]pyrazoles that exhibit glucocorticoid activity. The preparation involves treating a 6-unsubstituted-4,6-pregnadieno[3,2-c]pyrazole with a halogen azide, followed by treatment with a dehydrohalogenating agent. Other methods include treating a 6-azido-17.alpha.,20; 20,21-bismethylenedioxy-4,6-pregnadiene-3-one with an alkyl formate in the presence of base. The resulting compounds, particularly 6-azido-11.beta.,17.alpha.,21-trihydroxy-20-keto-4,6-pregnadieno[3,2-c]pyrazoles, are noted for their potent anti-inflammatory activity.

Career Highlights

Throughout his career, Thomas L. Popper has been associated with Schering Corporation, where he has contributed to various innovative projects. His work has been instrumental in advancing the understanding and application of glucocorticoid compounds in therapeutic settings.

Collaborations

Thomas has collaborated with notable colleagues such as Richard W. Draper and Elliot L. Shapiro. These collaborations have fostered a productive environment for innovation and research in the pharmaceutical industry.

Conclusion

Thomas L. Popper's contributions to the field of pharmaceuticals through his innovative patents and collaborations highlight the critical role of inventors in advancing medical science. His work continues to influence the development of effective treatments for inflammatory conditions.